Published in Am J Physiol Heart Circ Physiol on September 10, 2010
Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci (2013) 1.05
Increase in cardiac myosin heavy-chain (MyHC) alpha protein isoform in hibernating ground squirrels, with echocardiographic visualization of ventricular wall hypertrophy and prolonged contraction. J Exp Biol (2013) 0.85
Wolbachia as an "infectious" extrinsic factor manipulating host signaling pathways. Front Endocrinol (Lausanne) (2012) 0.82
Essential role of TEA domain transcription factors in the negative regulation of the MYH 7 gene by thyroid hormone and its receptors. PLoS One (2014) 0.82
Inhibition of DNA methylation attenuates low-dose cadmium-induced cardiac contractile and intracellular Ca(2+) anomalies. Clin Exp Pharmacol Physiol (2013) 0.81
Thyroid hormone is required for growth adaptation to pressure load in the ovine fetal heart. Exp Physiol (2012) 0.80
Distribution of histone3 lysine 4 trimethylation at T3-responsive loci in the heart during reversible changes in gene expression. Gene Expr (2012) 0.79
Interplay of chromatin modifications and non-coding RNAs in the heart. Epigenetics (2013) 0.78
The effects of slow skeletal troponin I expression in the murine myocardium are influenced by development-related shifts in myosin heavy chain isoform. J Physiol (2012) 0.78
microRNA and thyroid hormone signaling in cardiac and skeletal muscle. Cell Biosci (2017) 0.75
Translating the histone code. Science (2001) 56.77
The language of covalent histone modifications. Nature (2000) 44.92
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell (1999) 11.90
The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev (2000) 11.65
Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (1995) 11.53
A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (1995) 11.18
A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature (2006) 10.73
Non-coding RNA. Hum Mol Genet (2006) 10.57
Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat Genet (2004) 9.10
Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72
Histone and chromatin cross-talk. Curr Opin Cell Biol (2003) 8.69
Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 7.31
The genetic signatures of noncoding RNAs. PLoS Genet (2009) 6.72
Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res (2008) 6.43
Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (1997) 6.15
Histone H3 lysine 9 methylation and HP1gamma are associated with transcription elongation through mammalian chromatin. Mol Cell (2005) 5.96
Profile of histone lysine methylation across transcribed mammalian chromatin. Mol Cell Biol (2006) 5.01
Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev (1999) 4.92
Nuclear hormone receptors and gene expression. Physiol Rev (2001) 4.56
DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev (2005) 4.25
A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol (2004) 4.23
Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev (2009) 4.20
Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev (2006) 4.17
Do natural antisense transcripts make sense in eukaryotes? Gene (1998) 3.66
Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell (2006) 3.59
Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol (1998) 3.51
Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci U S A (1984) 3.05
Thyroid hormone receptor alpha isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature (1988) 2.56
Long non-coding RNAs in nervous system function and disease. Brain Res (2010) 2.53
RNA regulation of epigenetic processes. Bioessays (2009) 2.53
Histone modification patterns associated with the human X chromosome. EMBO Rep (2006) 1.99
Tsix silences Xist through modification of chromatin structure. Dev Cell (2005) 1.97
Control of cardiac myosin heavy chain gene expression. Microsc Res Tech (2000) 1.97
Histone H4 lysine 20 monomethylation promotes transcriptional repression by L3MBTL1. Oncogene (2008) 1.90
Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J Mol Endocrinol (1999) 1.85
Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol (1985) (2001) 1.79
Intergenic transcription and developmental regulation of cardiac myosin heavy chain genes. Am J Physiol Heart Circ Physiol (2007) 1.73
A global view of genomic information--moving beyond the gene and the master regulator. Trends Genet (2009) 1.72
Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol (2002) 1.63
Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells. Oncogene (2007) 1.58
Histone deacetylases: complex transducers of nuclear signals. Semin Cell Dev Biol (1999) 1.57
Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol (1997) 1.52
Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR. BMC Biotechnol (2007) 1.48
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol (2005) 1.42
The multiple facets of histone H4-lysine 20 methylation. Biochem Cell Biol (2009) 1.28
New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab (2007) 1.20
Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta (2004) 1.20
Gene regulation by thyroid hormone. Trends Endocrinol Metab (2000) 1.20
Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol (2006) 1.19
Histone modifications dictate specific biological readouts. J Genet Genomics (2009) 1.15
Role of antisense RNA in coordinating cardiac myosin heavy chain gene switching. J Biol Chem (2003) 1.15
A necessary good: nuclear hormone receptors and their chromatin templates. Mol Endocrinol (2001) 1.13
Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. J Biol Chem (1999) 1.13
Distinct and histone-specific modifications mediate positive versus negative transcriptional regulation of TSHalpha promoter. PLoS One (2010) 0.97
Negative regulation of TSHalpha target gene by thyroid hormone involves histone acetylation and corepressor complex dissociation. Mol Endocrinol (2009) 0.95
Interaction of thyroid hormone receptors with strong and weak cis-acting elements in the human alpha-myosin heavy chain gene promoter. J Biol Chem (1990) 0.95
Dynamics of coactivator recruitment and chromatin modifications during nuclear receptor mediated transcription. Mol Cell Endocrinol (2007) 0.93
Natural antisense transcripts regulate gene expression in an epigenetic manner. Biochem Biophys Res Commun (2010) 0.93
Differential epigenetic modifications of histones at the myosin heavy chain genes in fast and slow skeletal muscle fibers and in response to muscle unloading. Am J Physiol Cell Physiol (2009) 0.93
New insights into the functions and regulation of the transcriptional corepressors SMRT and N-CoR. Cell Div (2009) 0.93
Fractionation of rat ventricular nuclei. Biochem J (1980) 0.92
Thyroid hormone influences beta myosin heavy chain (beta MHC) expression. Biochem Biophys Res Commun (1994) 0.91
Functional consequences of altered cardiac myosin isoenzymes. Med Sci Sports Exerc (1986) 0.90
Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. Am J Physiol Heart Circ Physiol (2005) 0.88
Distinct kinetic properties of cardiac myosin isoforms revealed by in vitro studies. Adv Exp Med Biol (1998) 0.87
Molecular dynamics and nuclear receptor function. Trends Endocrinol Metab (2004) 0.86
Isomyosin distributions in rodent muscles: effects of altered thyroid state. J Appl Physiol (1985) (1990) 0.81
Chromatin structure and cardiac gene expression. J Mol Cell Cardiol (1998) 0.79
Differential regulation of the myosin heavy chain genes alpha and beta in rat atria and ventricles: role of antisense RNA. Thyroid (2008) 0.79
Thyroid hormone and the heart. Am J Med (1996) 0.78
Thyroid receptor plasticity in striated muscle types: effects of altered thyroid state. Am J Physiol (1998) 0.78
Chromatin remodelling of the cardiac beta-myosin heavy chain gene. Biochem J (1998) 0.76
Conditionally replicative and conjugative plasmids carrying lacZ alpha for cloning, mutagenesis, and allele replacement in bacteria. Plasmid (1996) 8.70
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Modification of yeast Cdc53p by the ubiquitin-related protein rub1p affects function of the SCFCdc4 complex. Genes Dev (1998) 3.84
CPF1, a yeast protein which functions in centromeres and promoters. EMBO J (1990) 3.65
Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature (1997) 3.10
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest (1999) 2.91
Crystal structure of CspA, the major cold shock protein of Escherichia coli. Proc Natl Acad Sci U S A (1994) 2.89
Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi. Infect Immun (1989) 2.56
Cold shock induces a major ribosomal-associated protein that unwinds double-stranded RNA in Escherichia coli. Proc Natl Acad Sci U S A (1996) 2.55
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther (2004) 2.55
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. Oncogene (2012) 2.41
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Solution NMR structure of the major cold shock protein (CspA) from Escherichia coli: identification of a binding epitope for DNA. Proc Natl Acad Sci U S A (1994) 2.20
Family of the major cold-shock protein, CspA (CS7.4), of Escherichia coli, whose members show a high sequence similarity with the eukaryotic Y-box binding proteins. Mol Microbiol (1994) 2.15
Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies. Diagn Microbiol Infect Dis (1991) 2.06
Electron cryomicroscopy and bioinformatics suggest protein fold models for rice dwarf virus. Nat Struct Biol (2001) 1.99
Cross-talk between the histidine protein kinase VanS and the response regulator PhoB. Characterization and identification of a VanS domain that inhibits activation of PhoB. J Biol Chem (1995) 1.93
Respiratory capacity of white, red, and intermediate muscle: adaptative response to exercise. Am J Physiol (1972) 1.88
Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85
A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology (2012) 1.77
Promoter-independent cold-shock induction of cspA and its derepression at 37 degrees C by mRNA stabilization. Mol Microbiol (1997) 1.77
Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification. Oncogene (1991) 1.59
Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi. J Immunol (1991) 1.55
De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet (1999) 1.50
Arrangement of the multicopy H+-translocating subunit c in the membrane sector of the Escherichia coli F1F0 ATP synthase. J Biol Chem (1998) 1.50
Recent transmission of W-Beijing family Mycobacterium tuberculosis in rural eastern China. Int J Tuberc Lung Dis (2012) 1.47
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation (2001) 1.46
Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types. J Physiol (2007) 1.46
Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem (1996) 1.44
Implantation of BM cells transfected with phVEGF165 enhances functional improvement of the infarcted heart. Cytotherapy (2004) 1.44
Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol (1998) 1.41
Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid. Cancer Res (2001) 1.40
Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol (2001) 1.39
Comments on classical papers. J Appl Physiol (1985) (2005) 1.39
Role of the motor cortex in the control of visually triggered gait modifications. Can J Physiol Pharmacol (1996) 1.38
Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun (1993) 1.38
Loss of a protein phosphatase 2A regulatory subunit (Cdc55p) elicits improper regulation of Swe1p degradation. Mol Cell Biol (2000) 1.36
A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am J Hum Genet (1999) 1.35
Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol (1985) (2006) 1.33
Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol (1995) 1.33
Structure of the membrane domain of subunit b of the Escherichia coli F0F1 ATP synthase. J Biol Chem (1999) 1.33
Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. Arch Intern Med (1997) 1.30
DNA binding of CPF1 is required for optimal centromere function but not for maintaining methionine prototrophy in yeast. Nucleic Acids Res (1991) 1.30
The 93-kilodalton protein of Borrelia burgdorferi: an immunodominant protoplasmic cylinder antigen. Infect Immun (1992) 1.30
The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci (1999) 1.29
BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol (1999) 1.29
Reduced virulence of Candida albicans mutants affected in multidrug resistance. Infect Immun (1995) 1.29
The fine structure and electrophysiology of heart muscle cell injury. J Cell Biol (1970) 1.28
Artificial gravity as a countermeasure to microgravity: a pilot study examining the effects on knee extensor and plantar flexor muscle groups. J Appl Physiol (1985) (2009) 1.26
Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle. J Appl Physiol (1985) (1996) 1.26
Effect of spaceflight on skeletal muscle: mechanical properties and myosin isoform content of a slow muscle. J Appl Physiol (1985) (1994) 1.25
Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J (2001) 1.21
Integrin activation and focal complex formation in cardiac hypertrophy. J Biol Chem (2000) 1.21
Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann Rheum Dis (2008) 1.20
Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J Biol Chem (2001) 1.20
Entrainment of the locomotor rhythm by group Ib afferents from ankle extensor muscles in spinal cats. Exp Brain Res (1992) 1.20
Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol (1985) (1999) 1.20
Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life. Association and hemodynamic features. Circulation (1995) 1.20
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19
Isometric resistance exercise fails to counteract skeletal muscle atrophy processes during the initial stages of unloading. J Appl Physiol (1985) (2005) 1.19
Coupling H(+) transport to rotary catalysis in F-type ATP synthases: structure and organization of the transmembrane rotary motor. J Exp Biol (2000) 1.19
Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload. Am J Physiol Heart Circ Physiol (2006) 1.18
Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res (1988) 1.18
Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. Mol Psychiatry (2007) 1.17
Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant (2007) 1.17
Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet (2000) 1.17
Functional significance of compensatory overloaded rat fast muscle. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.16
Overexpression of cyclin D1 enhances gene amplification. Cancer Res (1996) 1.16
Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol (1985) (2008) 1.16
Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochem Mol Biol Int (1996) 1.15
Overexpression of thioredoxin h leads to enhanced activity of starch debranching enzyme (pullulanase) in barley grain. Proc Natl Acad Sci U S A (1999) 1.15
Skeletal muscle myosin heavy chain composition and resistance training. J Appl Physiol (1985) (1993) 1.15
Glycolytic enzymes in different types of skeletal muscle: adaptation to exercise. Am J Physiol (1973) 1.14
Corrective responses to loss of ground support during walking. II. Comparison of intact and chronic spinal cats. J Neurophysiol (1994) 1.13
Estimating contrast transfer function and associated parameters by constrained non-linear optimization. J Microsc (2009) 1.13
Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog (1999) 1.13
Linkages between facial expressions of anger and transient myocardial ischemia in men with coronary artery disease. Emotion (2001) 1.12
Modulation of lemniscal input during conditioned arm movements in the monkey. Exp Brain Res (1988) 1.11
Observation of transient disorder during myosin subfragment-1 binding to actin by stopped-flow fluorescence and millisecond time resolution electron cryomicroscopy: evidence that the start of the crossbridge power stroke in muscle has variable geometry. Proc Natl Acad Sci U S A (1999) 1.11
Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene (1995) 1.11
Kinetics of binding and hydrolysis of a series of nucleoside triphosphates by actomyosin-S1. Relationship between solution rate constants and properties of muscle fibers. J Biol Chem (1993) 1.09
Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther (2001) 1.09
Cloning, expression, and chromosomal localization of the mouse meprin beta subunit. J Biol Chem (1993) 1.08
The backbone structure of the major cold-shock protein CS7.4 of Escherichia coli in solution includes extensive beta-sheet structure. J Biochem (1993) 1.08
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem (2000) 1.08
Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene (1995) 1.08
Insights into the rotary catalytic mechanism of F0F1 ATP synthase from the cross-linking of subunits b and c in the Escherichia coli enzyme. J Biol Chem (2000) 1.07
Prevalence and molecular diversity of Archaea in subgingival pockets of periodontitis patients. Oral Microbiol Immunol (2009) 1.07
Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats. J Appl Physiol (1985) (2007) 1.06
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. J Virol (2001) 1.06
Time course of soleus muscle myosin expression during hindlimb suspension and recovery. J Appl Physiol (1985) (1987) 1.06
The plasticity of skeletal muscle: effects of neuromuscular activity. Exerc Sport Sci Rev (1991) 1.06
Atrophy responses to muscle inactivity. I. Cellular markers of protein deficits. J Appl Physiol (1985) (2003) 1.05
In vivo post-translational processing and subunit reconstitution of cephalosporin acylase from Pseudomonas sp. 130. Eur J Biochem (1999) 1.04
Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ (1998) 1.04